Trump gets Pfizer to delay latest drug price hikes until year end
Enlarge / Prescription Drugs behind the counter at Boots the chemist in London, England, United Kingdom. (photo by Mike Kemp/In Pictures via Getty Images) (credit: Getty | Mike Kemp) Pfizer has agreed to roll back a round of price increases from July 1 that affected more than 100 medicines after President Donald Trump called the company’s CEO and had an “extensive discussion,” the company announced Tuesday. Now, Pfizer says it will return the drugs to their pre-July 1 list prices “as soon as technically possible,” and it will leave them there until either the President puts in place new healthcare policy or until the end of the year—whichever comes first. The idea is to “give the president an opportunity to work on his blueprint to strengthen the healthcare system and provide more access for patients,” Pfizer said in its announcement. Read 7 remaining paragraphs | Comments
Read more detail on Recent Technology posts –
Legal notice about the Trump gets Pfizer to delay latest drug price hikes until year end
rubric : Hukuki Net Legal News is not responsible for the privacy statements or other content from Web sites outside of the Hukuki.net site. Please refer the progenitor link to check the legal entity of this resource hereinabove.
Do you need High Quality Legal documents or forms related to Trump gets Pfizer to delay latest drug price hikes until year end?
- Trump Blue Print To Reduce Drug Costs Announced
- SEC Likely to Delay until 1Q 2012 Registration of Hedge Fund and Private Equity Fund Advisers, and Mid-Size Advisers Switching to State Regulation
- Innocent Until Proven Guilty — Or Not: An Economic Review of Market Power and Price Fixing Allegati
- Trump Taps 9 In Latest Round Of Judicial Nominations – Law360
- Unsatisfactory rating voided because employee's "performance review," failed to comply with the employer's own procedures and thus undermined the integrity of the process Joyce v City of New York, 2018 NY Slip Op 03433, Appellate Division, First Department The Appellate Division annulled the determination of respondent New York City Department of Education [DOE] sustaining the "unsatisfactory" rating for the 2010-2011 academic year give to John Joyce, a tenured teacher. The court said that the record demonstrates "deficiencies in the performance review process" that resulted in Mr. Joyce being given an unsatisfactory rating for the 2010-2011 academic year. Citing Matter of Gumbs v Board of Educ. of the City Sch. Dist. of the City of N.Y., 125 AD3d 484, and Matter of Richards v Board of Educ. of the City Sch. Dist. of the City of N.Y., 117 AD3d 605, the Appellate Division noted that these deficiencies "were not merely technical, but undermined the integrity and fairness of the process." Mr. Joyce had received a satisfactory rating for the previous academic year and, in contravention of its own procedures, DOE failed to place him on notice that he was in danger of receiving an unsatisfactory rating for the 2010-2011 academic year until after April 28, 2011. Although DOE's procedures required that tenured teachers in danger of receiving an unsatisfactory rating have "formal observations including a pre-observation and post-observation conference by the principal … as part of a prescriptive plan to improve their teaching," Mr. Joyce received only one formal observation which took place one week before the end of the academic year and was not part of a prescriptive plan to improve his performance as a teacher. The decision is posted on the Internet at: http://www.nycourts.gov/reporter/3dseries/2018/2018_03433.htm
- Trump reportedly praised Singapore for executing drug dealers. Here’s how they’re killed.
- The Year of Living Dangerously: One Year of President Trump — Top Five Most Memorable Moves by President Trump on Immigration Law and Enforcement. The Shutdown of the Federal Government.
- Regulation in the Trump Administration’s First Year
- Podcast: The Constitution in Year One of the Trump administration
- How to Read Michael Cohen's Latest Plea and Its Revelations About the Trump Organization